Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Food Chem ; 443: 138610, 2024 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-38301562

RESUMO

Given their multifaceted roles, carotenoids have garnered significant scientific interest, resulting in a comprehensive and intricate body of literature that occasionally presents conflicting findings concerning the proper characterization, quantification, and bioavailability of these compounds. Nevertheless, it is undeniable that the pursuit of novel carotenoids remains a crucial endeavor, as their diverse properties, functionalities and potential health benefits make them invaluable natural resources in agri-food and health promotion through the diet. In this framework, particular attention is given to ketocarotenoids, viz., astaxanthin (one of them) stands out for its possible multifunctional role as an antioxidant, anticancer, and antimicrobial agent. It has been widely explored in the market and utilized in different applications such as nutraceuticals, food additives, among others. Adonirubin and adonixanthin can be naturally found in plants and microorganisms. Due to the increasing significance of natural-based products and the remarkable opportunity to introduce these ketocarotenoids to the market, this review aims to provide an expert overview of the pros and cons associated with adonirubin and adonixanthin.


Assuntos
Cantaxantina/análogos & derivados , Carotenoides , Antioxidantes
2.
J Oleo Sci ; 62(3): 181-6, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23470446

RESUMO

Anti-oxidative, anti-tumor-promoting, and anti-carcinogenic activities of adonirubin and adonixanthin, which are biosynthetic intermediates from ß-carotene to astaxanthin, were investigated. Both adonirubin and adonixanthin showed almost the same activities for inhibition of lipid peroxidation and quenching of singlet oxygen as those of astaxanthin. Furthermore, adonirubin and adonixanthin exhibited an inhibitory effect on Epstein-Barr virus early antigen activation in Raji cells and carcinogensis of mouse skin tumors initiated by 7,12-dimethylbenz[a]anthracene and promoted by 12-O-tetradecanoylphorbol-13-acetate.


Assuntos
Anticarcinógenos/farmacologia , Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Cantaxantina/análogos & derivados , Carotenoides/farmacologia , Neoplasias Cutâneas/tratamento farmacológico , Proteínas da Matriz Viral/antagonistas & inibidores , 9,10-Dimetil-1,2-benzantraceno/antagonistas & inibidores , Animais , Anticarcinógenos/química , Anticarcinógenos/metabolismo , Antineoplásicos/química , Antineoplásicos/metabolismo , Antioxidantes/química , Antioxidantes/metabolismo , Cantaxantina/biossíntese , Cantaxantina/química , Cantaxantina/farmacologia , Carotenoides/biossíntese , Carotenoides/química , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos ICR , Estrutura Molecular , Paracoccus/química , Paracoccus/metabolismo , Oxigênio Singlete/química , Neoplasias Cutâneas/induzido quimicamente , Relação Estrutura-Atividade , Acetato de Tetradecanoilforbol/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA